Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: sites default files attachments FS NICE A4 1 pdf
… Republic of Ireland: NCPE Sweden: TLV United Kingdom: NICE , SMC, AWMSG In addition to global HTA submissions, we …
Surveys and Observational Studies Beyond the evidence standards set by traditional clinical trials, well-designed and implemented surveys and observational studies can help you, your patients, regulators, and prescribers understand the real-world use, …
… Early Dialog with NICE and EUnetHTA See the research: Early dialogue with NICE and EUnetHTA: a UK perspective in a politically … services offered by HTA bodies – EUnetHTA in Europe and NICE in the UK. These services are designed to guide the …
… If you have any questions, please contact Erin Kaplan at 1-919-541-5957. …
… 6 Takeaways on the AMCP 4.1 Guidance in Action Share on: March 12, 2021 Insights from … Academy of Managed Care Pharmacy (AMCP) released Version 4.1 of the AMCP Format for Formulary Submissions, which … . Please reach out if you have any questions. Download a PDF of our Guidance Summary Image …
… numerous recruitment techniques including working with sites, patient advocacy groups, patient panels, and social …
RTI Releases 2023 Corporate Responsibility and Sustainability Report Share on: February 7, 2024 Institute commits additional $9 million to internal sustainability investments to reduce GHG emissions RTI International, a nonprofit research institute, has …
Delphi Panels Image Having high-quality data to inform decision-making is critical to your product’s development and success. But sometimes, unanticipated questions arise, and you need information quickly. What do you do if the data you need is …
PIE and Post-Approval AMCP Dossiers Image Pre-Approval Information Exchange (PIE) Materials Unapproved Medical Product Dossiers and Unapproved Use Dossiers An unapproved product dossier, or an unapproved use dossier, allows you to communicate key product …
Multi-Criteria Decision Analysis Most drug development and commercialization choices are complex. When you have multiple factors influencing a decision and you have to consider tradeoffs, you need a tool that can help you compare, prioritize and select …